• No results found

chronic lymphocytic leukemia

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

... Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in Western countries and mainly affects elderly individuals. It follows an extremely variable course, with survival ...

7

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

... cell leukemia is another type of chronic leukemia of lympho- ...The Leukemia & Lymphoma Society patient education booklet entitled Hairy Cell ...with chronic lymphocytic ...in ...

44

CHRONIC LYMPHOCYTIC LEUKEMIA

CHRONIC LYMPHOCYTIC LEUKEMIA

... rather than 3 days [13]. An Australian study focused on fit patients aged 65 years and over also adopted this 5 day oral regimen as the method of administration [15]. More recently combination therapy with ...

8

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

... introduCtion Chronic lymphocytic leukemia (CLL) is the most common type of adult leukemia in the Western world, with approximately 10,000 new cases diagnosed each year in the United ...adult ...

12

Chronic lymphocytic leukemia

Chronic lymphocytic leukemia

... Chronic lymphocytic leukemia (CLL) is a B-cell lymphoproliferative disorder. The diagnosis of CLL requires the presence of 5x10 9 /L lymphocytes in the peripheral blood and infiltration of bone ...

33

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

... How Chronic Lymphocytic Leukemia (CLL) Develops. CLL results from one or more acquired mutations to the genetic material, called DNA, of a single bone marrow cell that would otherwise develop into a ...

60

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

... Familial Chronic Lymphocytic Leukemia phone line: 1-800-610-7043; National Cancer Institute [NCI] Fa- milial Chronic Lymphocytic Leukemia phone line: 1-800- 518-8474; ...

8

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

... Page 8 of 10 Chronic Lymphocytic Leukemia T-CLL T-CLL does appear to be a real, albeit rare entity, representing < 1% of all cases of CLL. Patients present with lymphocytosis, mild to moderate ...

10

Molecular pathogenesis of chronic lymphocytic leukemia

Molecular pathogenesis of chronic lymphocytic leukemia

... 4 Department of Pathology and Cell Biology, 5 Department of Genetics and Development, and 6 Department of Microbiology and Immunology, Columbia University, New York, New York, USA. Chronic lymphocytic ...

7

Chronic Lymphocytic Leukemia Treatment Market

Chronic Lymphocytic Leukemia Treatment Market

... Analysis: Chronic Lymphocytic Leukemia is a monoclonal disorder that is commonly known as Blood cancer, diagnosed majorly in men from western ...with Chronic Lymphocytic ...

14

Molecular pathogenesis of chronic lymphocytic leukemia

Molecular pathogenesis of chronic lymphocytic leukemia

... 4 Department of Pathology and Cell Biology, 5 Department of Genetics and Development, and 6 Department of Microbiology and Immunology, Columbia University, New York, New York, USA. Chronic lymphocytic ...

8

Apoptosis inducers in chronic lymphocytic leukemia

Apoptosis inducers in chronic lymphocytic leukemia

... CLL Chronic lymphocytic leukemia results from the clonal expansion of a CD5-positive subpopulation of B lymphocytes which progressively accumulate in the bone marrow, lymph nodes and peripheral ...

17

Targeted treatment for chronic lymphocytic leukemia

Targeted treatment for chronic lymphocytic leukemia

... Introduction Chronic lymphocytic leukemia (CLL) is one of the most common forms of leukemia in the Western hemisphere with an annual incidence of ...

15

Characteristics of chronic lymphocytic leukemia in Senegal

Characteristics of chronic lymphocytic leukemia in Senegal

... 21. Funaro A, Morra M, Calosso L, Zini MG, Ausiello CM. Malavasi F Role of the human CD38 molecule in B cell activation and proliferation. Tissue Antigens. 1997;49(1):7 – 15. 22. Damle RN, Wasil T, Fais F, Ghiotto F, ...

8

Therapeutic advancement of chronic lymphocytic leukemia

Therapeutic advancement of chronic lymphocytic leukemia

... 99. Milani C, Castillo J: Veltuzumab, an anti-CD20 mAb for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and immune thrombocytopenic purpura. Curr Opin Mol Ther 2009, 11:200 – ...

12

Novel agents for chronic lymphocytic leukemia

Novel agents for chronic lymphocytic leukemia

... Chronic lymphocytic leukemia (CLL) is a heterogeneous group of B-cell neoplasm. CLL is typically sensitive to a variety of cytotoxic agents, but relapse frequently occurs with conventional ...

8

Lymphoma and Chronic Lymphocytic Leukemia Clinical Trials

Lymphoma and Chronic Lymphocytic Leukemia Clinical Trials

... for Chronic Lymphocytic Leukemia has been subject to a wide range of ...for chronic lymphocytic leukemia (CLL) for the assessment of patients with CLL in clinical ...

20

The spectrum of use of rituximab in chronic lymphocytic leukemia

The spectrum of use of rituximab in chronic lymphocytic leukemia

... email [email protected] Abstract: The monoclonal chimeric anti-CD20 antibody, rituximab, has considerably improved therapeutic outcome in B-cell chronic lymphocytic leukemia. ...

20

Role of bendamustine in the treatment of chronic lymphocytic leukemia

Role of bendamustine in the treatment of chronic lymphocytic leukemia

... chemotherapy, chronic lymphocytic leukemia Introduction Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in the United States (US), with more than ...

8

The Danish National Chronic Lymphocytic Leukemia Registry

The Danish National Chronic Lymphocytic Leukemia Registry

... Acute Leukemia Registry, and The Danish National Myeloma ...National Chronic Lymphocytic Leukemia Registry was founded within the Danish National Hematology ...with chronic lympho- ...

5

Show all 10000 documents...

Related subjects